SOLIFENACIN / TAMSULOSIN (Vesomni®)
Clinical Indication
Benign prostatic hyperplasia
Date of classification
June 2015
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.